Cellular arrangement of human breast cancer cell lines determines hemostatic parameters

Tumor Biology

Volumn 19, Issue 2, 1998, Pages 104-112

  Barendsz Janson, Annemarie F ^a   Muller, Annemarie D ^b   Lichlenbdd, Hera U C ^a   Van Dam Mieras, Maria C E ^b   Hillen, Harry F P ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b OPEN UNIVERSITY OF THE NETHERLANDS   (Netherlands)

Author keywords

Coagulation; Extracellular matrix; Fibrinolysis; Proliferation; Spheroids

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; KI 67 ANTIGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN BCL 2; PROTEIN P53; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; BLOOD CLOTTING; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FIBRINOLYSIS; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; SPHEROID CELL;

EID: 0031929011     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029980     Document Type: Article

References (32)

1. References 1 Abcloff MD, Lichter AS, Niederhubcr JE, Pierce LJ, Aziz DC: Breast; in Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds): Clinical Oncology. New York, Churchill Livingstone, 1995, pp 1617-1714.
2. Gasparini G, Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool. J Clin Oncol 1995;13: 765-782.
3. Thompson EW, Paik S, Brünner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME, Martin GR, Dickson RB: Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992;150:534-544.
4. Lochter A, Bissell MJ: Involvement of extracellular matrix constituents in breast cancer. Semin Cancer Biol 1995;6:165-173.
5. Tannock IF: Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor. Cancer Res 1970;30:2470-2476.
6. Trousseau A: Phlegmasia alba dolens; in Trousseau A (ed): Clinique Médicale de L'Hôtel-Dieu de Paris. Paris, Balliere et Fils, 1885, pp 695705.
7. Nierodzik ML, Klepfish A, Karpatkin S: Role of platelets, thrombin, integrin Ilb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost 1995;74: 282-290.
8. Sutherland R, Carlsson J, Durand R, Yuhas J: Spheroids in cancer reseach. Cancer Res 1981 ;41:29802984.
9. Lichtenbeld HHC, Muller AD, Van Dam-Mieras MCE, Blijham GH: Tumor spheroid-induced vesicle formation on endothelial cells is associated with procoagulant properties. J Cell Sei 1993;106:657-662.
10. Sutherland RM, McCredie JA, Inch WR: Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst 1971;46:113-120.
11. Porter-Jordan K, Lippman ME: Overview of the biologic markers of breast cancer. Hematol Oncol Clin North Am 1994;8:73-100.
12. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 1994;54:20952097.
13. LeekRD,KaklamanisL,PezzellaF, Gatter KC, Harris AL: bcl-2 in normal human breast and carcinoma, association with oestrogen receptorpositive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 1994;69:135139.
14. Duffy MJ, Reilly D, McDermott E, O'Higgins N, Fennelly JJ, Andreasen PA: Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer. Cancer 1994;74: 2276-2280.
15. Foekens JA, Schmitt M, VanPutten WLJ, Peters HA, Bontebal M, Jänicke F, Klijn JGM: Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res 1992;52: 6101-6105.
16. Bruggeman CA, Debie WHM, Muller AD, Schutte B, Van Dam-Mieras MCE: Cytomegalovirus alters the von Willebrand factor content in human endothelial cells. Thromb Haemost 1988;59:264-268.
17. Muller AD, Lichtenbeld HHC, Blijham GH, Vossen RCRM, Van Dam-Mieras MCE: Mast cell lysate induces a procoagulant effect on endothelial cells. Thromb Res 1993; 72:263-267.
18. Pouplard C, Reverdiau-Moalic P, Piquemal R, Watier H, Lebranchu Y, Bardos P, Grad Y: A simplified and low-cost one-stage chromogenic assay for tissue factor dependent procoagulant activity of endothelial cells. Thromb Res 1995;80:527534.
19. Bas BM, Costongs GMPJ, Janson PCW: Rapid analysis of coagulation parameters by automated substrate methods with a Cobas Bio Centrifugal analyser. Haemostasis 1987; 17: 260-267.
20. Engel LW, Young NA: Human breast carcinoma cells in continuous culture: A review. Cancer Res 1978; 38:4327-4339.
21. Soule HD, Vazquez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973;51:1409-1416.
22. HackettAJ, Smith HS, Springer EL, Owens RB, Nelson-Rees WA, Riggs JL, Gardner MB: Two syngeneic cell lines from human breast tissue: The aneuploid mammary epithelial (Hs578T) and the diploid myoepithclial (Hs578Bst) cell lines. J Natl Cancer Inst 1977;58:1795-1806.
23. Olea N, Villalobos M, Ruiz de Almodovar JM, Pedraza V: MCF-7 breast cancer cells grown as multicellular spheroids in vitro: Effect of 17-estradiol. Int J Cancer 1992;50: 112-117.
24. Friedrich K.Dimmet V.HaroskeG, Lossnitzer A, Kasper M, Theissig F, Kunze KD: Expression of p53 and bcl-2 in correlation to clinicopathological parameters, hormone receptor status and DNA ploidy in breast cancers. Pathol Res Pract 1995; 191: 1114-1121.
25. Cattoretti G, Rilke F, Andreola S, D'Amato L, Délia D: P53 expression in breast cancer. Int J Cancer 1988;41:178-183.
26. Cattoretti G, Decker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki67 antigen (MIB1 and MIB3) detect proliferating cells in microwave processed formalin fixed paraffin sections. J Pathol 1992;168:357-363.
27. Okada N, Fushimi M, Nagata Y, Fukunaga T, Tsutsumi Y: A quantitative in vivo method of analyzing human tumor-induced angiogenesis in mice using agarose microencapsulation and hemoglobin enzymelinked immunosorbent assay. Jpn J Cancer Res 1995;86:1182-1188.
28. Gui GPH, Puddefoot JR, Vinson GP, Wells CA, Carpenter R: In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix. Br J Surg 1995;82:11921196.
29. Stadler E, Dziadek M: Extracellular matrix penetration by epithelial cells is influenced by quantitative changes in basement membrane components and growth factors. Exp Cell Res 1996;229:360-369.
30. Sommers CL, Gelmann EP, Kemler R, Cowin P, Byers SW: Alterations in -catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 1994;54:3544-3552.
31. Foekens JA, Schmitt M, VanPutten WLJ, Peters HA, Kramer MD, Jänicke F, Klijn JGM: Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. J Clin Oncol 1994;12:1648-1658.
32. Donati MB, Poggi A, Semeraro N: Coagulation and malignancy; in Poller L (ed): Recent Advances in Blood Coagulation. Edinburgh, Churchill Livingstone, 1981, vol 3, pp 227-259.